Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Darrah

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Editorial: citrullination, and carbamylation, and malondialdehyde-acetaldehyde! Oh my! Entering the forest of autoantigen modifications in rheumatoid arthritisErika Darrah, Felipe Andrade
Frontiers in Immunology|January 22, 2013
NETs: the missing link between cell death and systemic autoimmune diseases?Erika Darrah, Felipe Andrade
Current Opinion in Rheumatology|September 23, 2017
Rheumatoid arthritis and citrullinationErika Darrah, Felipe Andrade
Current Opinion in Rheumatology|September 10, 2021
Insights into origins and specificities of autoantibodies in systemic sclerosisEleni Tiniakou, Jonathan Crawford, Erika Darrah
Arthritis & Rheumatology (Hoboken, N.J.)|December 27, 2019
Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell DamageVioleta Romero, Erika Darrah, Felipe Andrade
Immunological Reviews|December 27, 2019
Insights into the study and origin of the citrullinome in rheumatoid arthritisJustyna Fert-Bober, Erika Darrah, Felipe Andrade
Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Insights into the significance of peptidylarginine deiminase 4 and antibodies against citrullinated antigens in the absence of "true ACPAs" in an experimental model of arthritis: comment on the article by Shelef et alMaximilian F Konig, Erika Darrah, Felipe Andrade
The Journal of Rheumatology|January 17, 2019
Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 AntibodiesErika Darrah, Laura Martinez-Prat, Michael Mahler
Journal of Clinical Medicine|August 29, 2019
Rheumatoid Arthritis-Associated Mechanisms of <i>Porphyromonas gingivalis</i> and <i>Aggregatibacter actinomycetemcomitans</i>Eduardo Gómez-Bañuelos, Amarshi Mukherjee, Erika Darrah, et al.
Annals of the Rheumatic Diseases|August 24, 2011
Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritisErika Darrah, Antony Rosen, Jon T Giles, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Arthritis & Rheumatology (Hoboken, N.J.)|December 4, 2014
Editorial: citrullination, and carbamylation, and malondialdehyde-acetaldehyde! Oh my! Entering the forest of autoantigen modifications in rheumatoid arthritisErika Darrah, Felipe Andrade
Frontiers in Immunology|January 22, 2013
NETs: the missing link between cell death and systemic autoimmune diseases?Erika Darrah, Felipe Andrade
Current Opinion in Rheumatology|September 23, 2017
Rheumatoid arthritis and citrullinationErika Darrah, Felipe Andrade
Current Opinion in Rheumatology|September 10, 2021
Insights into origins and specificities of autoantibodies in systemic sclerosisEleni Tiniakou, Jonathan Crawford, Erika Darrah
Arthritis & Rheumatology (Hoboken, N.J.)|December 27, 2019
Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell DamageVioleta Romero, Erika Darrah, Felipe Andrade
Immunological Reviews|December 27, 2019
Insights into the study and origin of the citrullinome in rheumatoid arthritisJustyna Fert-Bober, Erika Darrah, Felipe Andrade
Arthritis & Rheumatology (Hoboken, N.J.)|June 4, 2014
Insights into the significance of peptidylarginine deiminase 4 and antibodies against citrullinated antigens in the absence of "true ACPAs" in an experimental model of arthritis: comment on the article by Shelef et alMaximilian F Konig, Erika Darrah, Felipe Andrade
The Journal of Rheumatology|January 17, 2019
Clinical Utility of Antipeptidyl Arginine Deiminase Type 4 AntibodiesErika Darrah, Laura Martinez-Prat, Michael Mahler
Journal of Clinical Medicine|August 29, 2019
Rheumatoid Arthritis-Associated Mechanisms of <i>Porphyromonas gingivalis</i> and <i>Aggregatibacter actinomycetemcomitans</i>Eduardo Gómez-Bañuelos, Amarshi Mukherjee, Erika Darrah, et al.
Annals of the Rheumatic Diseases|August 24, 2011
Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritisErika Darrah, Antony Rosen, Jon T Giles, et al.
Pageof 7